TITLE

Chronic granulocytic leukaemia and chronic lymphocytic leukaemia

AUTHOR(S)
Spiers, A S
PUB. DATE
November 1974
SOURCE
British Medical Journal;11/23/1974, Vol. 4 Issue 5942, p460
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64322242

 

Related Articles

  • THE EFFECT OF DRUGS ON THE OXYGEN UPTAKE OF CELLS FROM PATIENTS WITH CHRONIC GRANULOCYTIC LEUKAEMIA. Antonas, K. N.; Onesti, P.; Woodliff, H. J. // Australian Journal of Experimental Biology & Medical Science;Dec1965, Vol. 43 Issue 6, p751 

    The article discusses the effect of drugs on the oxygen uptake of cells in patients with chronic granulocytic leukaemia. During an attempt to develop an in vitro sensitivity test of leukaemia cells to chemotherapeutic drugs, oxygen uptake studies were carried out on cells from patients with...

  • Chronic lymphocytic leukaemia.  // Cancer Nursing Practice;Nov2007, Vol. 6 Issue 9, p35 

    A quiz concerning the self-assessment in chronic lymphocytic leukaemia is presented.

  • leukaemia, chronic lymphocytic. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p464 

    An encyclopedia entry for "chronic lymphocytic leukaemia" is presented. It refers to a type of leukaemia that is caused by a proliferation of mature lymphocytes. Symptoms of chronic lymphocytic leukaemia may include enlargement of the liver, spleen and lymph nodes, persistent fever and night...

  • leukaemia, chronic myeloid.  // BMA A-Z Family Medical Encyclopedia;2004, p464 

    An encyclopedia entry for "chronic myeloid leukaemia" is presented. It refers a type of leukaemia that is caused by the overproduction of granulocytes or neutrophils. Chronic myeloid leukaemia, which is also called chronic granulocytic leukaemia, usually has two phases, namely chronic and acute...

  • Bendamustine.  // Reactions Weekly;Nov2015, Vol. 1577 Issue 1, p59 

    The article presents a case study of a 55-year-old man who developed leukaemia cutis following treatment with bendamustine for chronic lymphocytic leukaemia (CLL).

  • Rituximab.  // Reactions Weekly;7/31/2010, Issue 1312, p40 

    The article describes the case of a man who developed pneumonia during treatment with rituximab for chronic lymphocytic leukaemia (CLL).

  • Alemtuzumab.  // Reactions Weekly;Apr2015, Vol. 1547 Issue 1, p19 

    The article presents case studies of patients with chronic lymphocytic leukaemia, who developed virus reactivations during alemtuzumab treatment.

  • Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy. Milojković, D.; Aldouri, M.; Pagliuca, A.; Mufti, G. J.; Devereux, S. // Bone Marrow Transplantation;Sep2006, Vol. 38 Issue 6, p461 

    A letter to the editor is presented in response to the article about the prolonged remission in a B-cell chronic lymphocytic leukaemia's transformation is presented.

  • Rituximab approved for first-line use in chronic lymphocytic leukaemia.  // British Journal of Hospital Medicine (17508460);Apr2009, Vol. 70 Issue 4, p189 

    The article reports on the approval of rituximab for first-line use in chronic lymphocytic leukaemia.

  • Recurrent penile ulcer as a manifestation of chronic lymphocytic leukaemia. Antoniou, Christina; Stefanaki, Christina; Ioannidou, Dikaia; Tasidou, Anna; Pigaditou, Anna; Katsambas, Andreas // International Journal of STD & AIDS;Nov2008, Vol. 19 Issue 11, p795 

    A letter to the editor regarding a case of penile ulcerative recurrent lesions in chronic lymphocytic leukaemia is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics